These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 6714679)
21. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease. Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413 [TBL] [Abstract][Full Text] [Related]
22. Early combination therapy with bromocriptine and levodopa in Parkinson's disease. Factor SA; Weiner WJ Mov Disord; 1993 Jul; 8(3):257-62. PubMed ID: 8341289 [TBL] [Abstract][Full Text] [Related]
23. Drugs for parkinsonism. Med Lett Drugs Ther; 1988 Dec; 30(781):113-6. PubMed ID: 3143051 [No Abstract] [Full Text] [Related]
24. A comparative study of bromocriptine and levodopa in Parkinson's disease. Duvoisin RC; Mendoza MM; Yahr MD Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618 [No Abstract] [Full Text] [Related]
26. Practical therapeutics: advances in the management of Parkinson's disease. Adam AM East Afr Med J; 1985 Feb; 62(2):143-6. PubMed ID: 3930202 [No Abstract] [Full Text] [Related]
27. Drug management of Parkinson's disease. Kishore A; Snow BJ Can Fam Physician; 1996 May; 42():946-52. PubMed ID: 8688697 [TBL] [Abstract][Full Text] [Related]
28. Understanding Parkinson's disease: detection and early disease management. Mackin LA Lippincotts Prim Care Pract; 2000; 4(6):595-607. PubMed ID: 11933373 [TBL] [Abstract][Full Text] [Related]
29. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Vitek JL; Bakay RA; Freeman A; Evatt M; Green J; McDonald W; Haber M; Barnhart H; Wahlay N; Triche S; Mewes K; Chockkan V; Zhang JY; DeLong MR Ann Neurol; 2003 May; 53(5):558-69. PubMed ID: 12730989 [TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and treatment of tremor in Parkinson's disease and essential tremor]. Wolters A; Benecke R MMW Fortschr Med; 2007 May; 149 Suppl 2():94-6. PubMed ID: 17724978 [TBL] [Abstract][Full Text] [Related]
31. [Parkinson disease. The clinical picture and therapy]. Huber M Dtsch Med Wochenschr; 1988 Jun; 113(24):992-8. PubMed ID: 2897901 [No Abstract] [Full Text] [Related]
32. Role of integrative pharmacokinetic and pharmacodynamic optimization strategy in the management of Parkinson"s disease patients experiencing motor fluctuations with levodopa. Okereke CS J Pharm Pharm Sci; 2002; 5(2):146-61. PubMed ID: 12207867 [TBL] [Abstract][Full Text] [Related]
33. Management of the patient with newly-diagnosed Parkinson's disease. Paulson GW Geriatrics; 1993 Feb; 48(2):30-4, 39-40. PubMed ID: 8094362 [TBL] [Abstract][Full Text] [Related]
34. Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease. Hauser RA; Holford NH Mov Disord; 2002 Sep; 17(5):961-8. PubMed ID: 12360545 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive care of the patient with Parkinson's disease. Lannon MC; Thomas CA; Bratton M; Jost MG; Lockhart-Pretti P J Neurosci Nurs; 1986 Jun; 18(3):121-31. PubMed ID: 2941497 [TBL] [Abstract][Full Text] [Related]
36. [Initial manifestations of Parkinson disease. Diagnosis and differential diagnosis]. Uldry PA; Regli F Rev Med Suisse Romande; 1991 Jan; 111(1):3-8. PubMed ID: 2006361 [No Abstract] [Full Text] [Related]